Home › Funds › Vivo Capital, LLC › ALXO
Vivo Capital, LLC position in ALXO
ALX ONCOLOGY HLDGS INC · Health Care
Vivo Capital, LLC reported holding 3,184,713 shares of ALXO (ALX ONCOLOGY HLDGS INC) in its Q2 2026 13F filing — a position valued at US$6.6M, representing 0.60% of its reported portfolio and ranking #36 among its reported holdings. Vivo Capital, LLC has disclosed ALXO holdings in 7 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Vivo Capital, LLC's ALXO position evolved
Vivo Capital, LLC first disclosed a stake in ALXO in Q3 2023 at 4,220,048 shares (US$20.3M). The position peaked in Q4 2023 at 4,220,048 shares, worth US$62.8M. Across 7 filings, Vivo Capital, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 3,184,713 shares valued at US$6.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.22M | $20.26M | New |
| Q4 2023 | 4.22M | $62.84M | Hold |
| Q1 2024 | 4.22M | $47.05M | Hold |
| Q2 2024 | 4.22M | $25.45M | Hold |
| Q3 2024 | 4.03M | $7.34M | Reduce |
| Q1 2026 | 3.18M | $6.39M | New |
| Q2 2026 | 3.18M | $6.59M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALXO and 13F data
ALXO (ALX ONCOLOGY HLDGS INC) is a Health Care company. 35 other funds we track also report a position in ALXO — the largest reported positions include venBio Partners LLC (US$26.7M), Redmile Group, LLC (US$15.3M), SILVERARC CAPITAL MANAGEMENT, LLC (US$11.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALXO
- venBio Partners LLC 12.88M sh · $26.67M · Q2 2026
- Redmile Group, LLC 7.39M sh · $15.30M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 5.74M sh · $11.89M · Q2 2026
- TCG Crossover Management, LLC 5.66M sh · $11.71M · Q2 2026
- 5AM Venture Management, LLC 3.06M sh · $6.33M · Q2 2026
- Almitas Capital LLC 2.94M sh · $6.08M · Q2 2026
More on Vivo Capital, LLC
FAQ
How long has Vivo Capital, LLC held ALXO?
Vivo Capital, LLC has disclosed ALXO holdings in 7 of the last 12 reported quarters, going back to Q3 2023.
What is Vivo Capital, LLC's current position in ALXO?
As of Q2 2026, Vivo Capital, LLC holds 3.18M shares of ALXO (ALX ONCOLOGY HLDGS INC), valued at $6.59M, representing 0.60% of its reported portfolio and ranking #36.
Has Vivo Capital, LLC been buying or selling ALXO?
In the latest 13F filing (Q2 2026), Vivo Capital, LLC held unchanged its position in ALXO. The position peaked in Q4 2023 at 4.22M shares.
Which other funds hold ALXO?
Other major institutional holders of ALXO include venBio Partners LLC, Redmile Group, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.